Age-related macular degeneration;La dégénérescence maculaire liée à l'âge

Revue de Medecine Interne

Volumn 29, Issue 3, 2008, Pages 215-223

  Parier, V ^a   Soubrane, G ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Age related macular degeneration; Angiography; Laser photocoagulation; Optical coherence tomography; Pegaptanib; Photodynamic therapy; Ranibizumab

Indexed keywords

PEGAPTANIB; RANIBIZUMAB; VERTEPORFIN; ANGIOGENESIS INHIBITOR; APTAMER; MONOCLONAL ANTIBODY; PHOTOSENSITIZING AGENT; PORPHYRIN; VASCULOTROPIN A;

AGING; ANGIOGRAPHY; BLINDNESS; CLINICAL FEATURE; DIET SUPPLEMENTATION; HUMAN; LASER COAGULATION; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; SHORT SURVEY; TREATMENT PLANNING; AGE; AGED; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; GENETICS; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PHOTOCHEMOTHERAPY; RETINA MACULA DEGENERATION; REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; APTAMERS, NUCLEOTIDE; DIETARY SUPPLEMENTS; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; MACULAR DEGENERATION; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42149136021     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.08.021     Document Type: Short Survey

References (31)

1. Soubrane G., Coscas G., Souied E., et al. Les DMLAs. Rapport de la société française d'ophtalmologie (2007), Masson, Paris
2. Augood C.A., Vingerling J.R., de Jong P.T., Chakravarthy U., Seland J., Soubrane G., et al. Prevalence of age-related maculopathy in older Europeans: the European eye study (EUREYE). Arch Ophthalmol 124 (2006) 529-535
3. Kimura K., Isashiki Y., Sonoda S., Kakiuchi-Matsumoto T., and Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130 (2000) 769-773
4. Souied E.H., Benlian P., Amouyel P., Feingold J., Lagarde J.P., Munnich A., et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125 (1998) 353-359
5. Seddon J.M., Cote J., Davis N., and Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121 (2003) 785-792
6. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
7. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
8. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
9. Allikmets R., Shroyer N.F., Singh N., Seddon J.M., Lewis R.A., Bernstein P.S., et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277 (1997) 1805-1807
10. Jakobsdottir J., Conley Y.P., Weeks D.E., Mah T.S., Ferrell R.E., and Gorin M.B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77 (2005) 389-407
11. Vingerling J.R., Hofman A., Grobbee D.E., and de Jong P.T. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 114 (1996) 1193-1196
12. Huang D., Swanson E.A., Lin C.P., Schuman J.S., Stinson W.G., Chang W., et al. Optical coherence tomography. Science 254 (1991) 1178-1181
13. Coscas G., Coscas F., Zourdani A., and Soubrane G. Optical coherence tomography and ARMD. J Fr Ophtalmol 27 (2004) 3S7-30
14. Ferris F.L., Davis M.D., Clemons T.E., Lee L.Y., Chew E.Y., Lindblad A.S., et al., Age-related eye disease study research group. A simplified severity scale fro age-related macular degeneration. Arch Ophthalmol 123 (2005) 1570-1574 AREDS report no. 18
15. Davis M.D., Gangnon R.E., Lee L.Y., Hubbard L.D., Klein B.E., Klein R., et al., Age-related eye disease study research group. The age-related eye disease study severity scale for age-related macular degeneration. Arch Ophthalmol 123 (2005) 1484-1498 AREDS report no. 17
16. Gass J.D. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63 Suppl (1967) 1-139
17. Gass J.D. Serous retinal pigment epithelial detachment with a notch. A sign of occult choroidal neovascularization. Retina 4 (1984) 205-220
18. Piguet B., Schalenbourg A., and Zografos L. Value of indocyanine green angiography in localization of occult choroid neovascularization. Klin Monatsbl Augenheilkd 208 (1996) 327-329
19. Verteporfin in photodynamic therapy study group. Verteporfin therapr of subfoveal choroidal neovascularization in age-related macular degeneration:-two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Arch Ophtalmol 132 (2001) 541-560
20. MPS group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophtalmol 100 (1982) 912-918
21. Coscas G., and Soubrane G. Argon laser photocoagulation of subretinal neovascularization in senile macular degeneration. Results of a randomized study of 60 cases. Bull Mem Soc Fr Ophtalmol 94 (1982) 149-154
22. Bressler N.M., and Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:-two-year results of two randomized clinical trials-tap report 2. Arch Ophtalmol 119 (2001) 198-207
23. Chakravarthy U., Adamis A.P., Cunningham Jr. E.T., Goldbaum M., Guyer D.R., Katz B., et al., VEGF inhibition study in ocular neovascularization (V.i.s.i.o.n.) clinical trial group. Year 2 efficacy results of two randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113 (2006) 1508. e1-25
24. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., et al., Marina Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
25. Brown D.M., Kaiser P.K., Michels M., Soubrane G., Heier J.S., Kim R., et al., Anchor Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
26. Ishibashi T., Miki K., Sorgente N., Patterson R., and Ryan S.J. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 103 (1985) 708-711
27. Penfold P.L., Gyory J.F., Hunyor A.B., and Billson F.A. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol 23 (1995) 293-298
28. Gillies M.C., Simpson J.M., Billson F.A., Luo W., Penfold P., Chua W., et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 122 (2004) 336-340
29. Penn J.S., Rajaratnam V.S., Collier R.J., and Clark A. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 42 (2001) 283-290
30. Slakter J.S., Bochow T.W., D'Amico D.J., Marks B., Jerdan J., Sullivan E.K., et al., Anecortave acetate clinical study group. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology 113 (2006) 3-13
31. Age-related eye disease study research group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophtalmol 119 (2001) 1417-1436 AREDS report no. 8